Relay Therapeutics Inc.
RLAY | NASDAQ
$18.19
-$0.65 (-3.45%)
At close: Sep 21, 2026, 4:00 PM ET
$18.27
+$0.08 (+0.45%)
Pre-market:
Sep 22, 2026, 7:43 AM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 10.35M | 10.68M | 15.36M | 8.36M | 8.36M | 7.68M | 10.01M | 10.01M | 35.21M | 35.33M | 25.55M | 25.8M | 942K | 1.19M | 1.38M | 1.7M | 2.02M | 2.5M | 3.03M | 85.12M | 84.45M | 83.61M |
Cost of Revenue | 68.99M | 130.46M | 129.96M | 193.79M | 202.52M | 233.04M | 315.44M | 324.88M | 329.75M | 325.96M | 326.39M | 316.45M | 301.86M | 274.17M | 243.01M | 230.16M | 207.41M | 192.05M | 171M | 120.84M | 76.68M | 31.53M |
Gross Profit | -58.64M | -119.79M | -114.6M | -185.43M | -194.16M | -225.36M | -305.43M | -314.87M | -294.55M | -290.64M | -300.84M | -290.65M | -300.91M | -272.98M | -241.62M | -228.46M | -205.4M | -189.55M | -167.98M | -35.72M | 7.77M | 52.07M |
Operating Income | -310.44M | -296.46M | -302.74M | -327.09M | -343.06M | -366.97M | -372.47M | -379.69M | -356.89M | -362.19M | -373M | -353.66M | -365.97M | -337.73M | -299.28M | -294.15M | -269.25M | -385.01M | -364.7M | -261.99M | -237.6M | -71.74M |
Interest Income | 24.58M | 24.57M | 27.04M | 30.3M | 32.17M | 33.61M | 34.75M | 34.47M | 34.04M | 33.06M | 31.05M | 27.72M | 21.59M | 15.03M | 8.79M | 3.68M | 2.13M | 1.3M | 830K | 859K | 1.24M | 2.05M |
Pretax Income | -286.04M | -272.71M | -276.48M | -297.59M | -311.55M | -333.39M | -337.71M | -345.2M | -322.83M | -329.12M | -341.97M | -325.98M | -344.42M | -322.7M | -290.51M | -290.46M | -267.12M | -383.73M | -363.87M | -261.14M | -236.39M | -69.71M |
Net Income | -286.04M | -272.71M | -276.48M | -297.59M | -311.55M | -333.39M | -337.71M | -345.2M | -322.83M | -329.12M | -341.97M | -325.98M | -344.42M | -322.7M | -290.51M | -290.46M | -267.12M | -383.73M | -363.87M | -261.14M | -236.39M | -69.71M |
Selling & General & Admin | 51.18M | 50.24M | 57.96M | 65.55M | 72.79M | 79.18M | 80.24M | 80.09M | 78.82M | 78.8M | 78.58M | 77.91M | 75.49M | 72.84M | 69.33M | 65.08M | 64.51M | 61.47M | 58.13M | 58M | 54.73M | 46.36M |
Research & Development | 270.72M | 258.14M | 261.38M | 274.04M | 282.4M | 310.5M | 319.09M | 328.51M | 333.39M | 329.59M | 330.02M | 319.8M | 305.21M | 277.52M | 246.36M | 230.99M | 209.06M | 316.7M | 295.65M | 275.16M | 254.56M | 108.08M |
Other Expenses | -70.11M | -131.71M | -131.21M | -197.93M | -206.29M | -248.06M | -332.3M | -343.78M | -349.86M | -336.85M | -336.44M | -334.7M | -315.64M | -285.6M | -258.03M | -230.38M | -209.72M | -182.7M | -157.06M | -106.89M | -63.91M | -30.62M |
Operating Expenses | 251.79M | 176.67M | 188.13M | 141.65M | 148.9M | 141.62M | 67.03M | 64.81M | 62.35M | 71.55M | 72.16M | 63.01M | 65.06M | 64.75M | 57.65M | 65.68M | 63.85M | 195.46M | 196.72M | 226.27M | 245.37M | 123.82M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 427K | 571K | 571K | 4.81M | 4.39M | 4.24M | 4.24M | 4.25M | 4.25M | 4.25M | 4.25M | 4.24M | 4.24M | 4.24M | 4.24M | 1.08M | 2.14M | 2.14M | 2.14M | 1.07M | n/a | n/a |
Cost & Expenses | 320.79M | 307.14M | 318.09M | 335.44M | 351.42M | 374.65M | 382.48M | 389.69M | 392.1M | 397.51M | 398.55M | 379.46M | 366.91M | 338.92M | 300.66M | 295.84M | 271.26M | 387.51M | 367.73M | 347.1M | 322.05M | 155.35M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 202.85M | 179.85M | 171.59M | 172.39M | 171.26M | 169.23M | 167.34M | 140.23M | 132.82M | 130.84M | 122.58M | 122.23M | 121.68M | 121.32M | 120.97M | 110.91M | 108.64M | 108.29M | 102.75M | 92.69M | 91.94M | 90.2M |
Shares Outstanding (Diluted) | 202.85M | 179.85M | 171.59M | 172.39M | 171.26M | 169.23M | 167.34M | 140.23M | 132.82M | 130.84M | 122.58M | 122.23M | 121.68M | 121.32M | 120.97M | 110.91M | 108.64M | 108.29M | 102.75M | 92.69M | 91.94M | 90.2M |
EPS (Basic) | -1.57 | -1.57 | -1.62 | -1.75 | -1.95 | -2.23 | -2.39 | -2.62 | -2.53 | -2.65 | -2.75 | -2.43 | -2.68 | -2.58 | -2.34 | -2.64 | -2.51 | -3.90 | -3.89 | -2.73 | -2.58 | -6.54 |
EPS (Diluted) | -1.57 | -1.57 | -1.62 | -1.75 | -1.95 | -2.23 | -2.39 | -2.62 | -2.53 | -2.65 | -2.75 | -2.43 | -2.68 | -2.58 | -2.34 | -2.64 | -2.51 | -3.90 | -3.89 | -2.73 | -2.58 | -6.54 |
EBITDA | -286.88M | -273.41M | -276.48M | -293.3M | -306.64M | -348.03M | -362.97M | -381.19M | -367.87M | -363.97M | -374.15M | -363.49M | -371.68M | -341.46M | -306.82M | -289.55M | -265.93M | -247.04M | -222.18M | -121.04M | -98.76M | -67.85M |
EBIT | -286.04M | -272.71M | -276.48M | -297.59M | -311.55M | -353.31M | -368.44M | -386.69M | -373.37M | -369.44M | -379.42M | -368.55M | -376.41M | -345.82M | -310.95M | -293.54M | -269.9M | -251.02M | -226.11M | -124.84M | -102.46M | -71.46M |
Depreciation & Amortization | -842K | -704K | n/a | 4.29M | 4.91M | 5.28M | 5.46M | 5.51M | 5.5M | 5.47M | 5.27M | 5.06M | 4.73M | 4.35M | 4.13M | 4M | 3.98M | 3.98M | 3.92M | 3.8M | 3.7M | 3.61M |
Add to Watchlist
Select watchlists to add or remove RLAY